ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747451; 2) Community: the network communities that were significantly associated with the response to NSC 747451; 3) Molecule: the relationships between components within communities and NSC 747451; 4) MDR: the compounds that were significantly associated with the NSC 747451.

NSC Compound Enrichment Correlation
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.038506707102734 0.19829699
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.038506707102734 0.45773993
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.038506707102734 0.39684306
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.038506707102734 0.44853604
NSC 624153 Null 0.038506707102734 0.53640246
NSC 629868 Null 0.038506707102734 -0.20260681
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.038506707102734 0.398147
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.038506707102734 0.54437885
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.038506707102734 0.45599763
NSC 645317 Sanguilutine pseudobase 0.038506707102734 0.60016789
Total:190  Current:137    [First] [Prev] [Next] [Last]